26,499,076 shares of MIRA Pharmaceuticals, Inc. (Nasdaq: MIRA) common stock were present or represented by proxy at the company's 2026 Annual Meeting of Stockholders on September 11, 2026, representing 63.06% of the 42,022,087 shares outstanding as of the July 21, 2026 record date. All three proposals on the ballot passed.
Director vote
Five directors were returned to the board: Erez Aminov, Matthew Pratt Whalen, Matthew Del Giudice, M.D., Denil Nanji Shekhat, M.D., and Edward MacPherson, each to serve until the next annual meeting or until their successors are duly elected and qualified. Broker non-votes held uniform at 5,713,034 across all five nominees. The Aminov line reconciles the count: 20,559,502 for, plus 226,540 withheld, plus 5,713,034 broker non-votes sums to 26,499,076.
| Nominee | Votes for | Broker non-votes |
|---|---|---|
| Erez Aminov | 20,559,502 | 5,713,034 |
| Matthew Pratt Whalen | 20,560,180 | 5,713,034 |
| Matthew Del Giudice, M.D. | 20,558,412 | 5,713,034 |
| Denil Nanji Shekhat, M.D. | 20,138,206 | 5,713,034 |
| Edward MacPherson | 20,435,527 | 5,713,034 |
Shekhat drew the lowest "for" count of the five at 20,138,206, roughly 422,000 votes below Whalen's 20,560,180. Each of the 42,022,087 outstanding shares carried one vote per matter at the meeting.
Auditor ratification and contingency
Salberg & Company, P.A. was ratified as independent registered public accounting firm for fiscal year ending December 31, 2026. The vote: 25,950,852 for, 158,064 against, 390,160 abstentions, no broker non-votes. Those three figures sum to 26,499,076, reconciling to the full quorum. The against share was 158,064 of 26,499,076 total present, under 0.6%.
Proposal 3 authorized an adjournment to gather additional proxies if needed. It cleared 24,897,741 to 1,205,307, with 396,028 abstentions. The contingency was not triggered.
The proposals were described in MIRA's definitive proxy statement filed with the SEC on July 28, 2026. MIRA, an emerging growth company incorporated in Florida, trades on the Nasdaq Capital Market with principal offices at 1200 Brickell Avenue, Suite 1950, Miami. Chief Executive Officer Erez Aminov signed the September 16, 2026 8-K.